These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 32977006)

  • 41. Extracellular vesicle-based drug delivery systems for cancer treatment.
    Walker S; Busatto S; Pham A; Tian M; Suh A; Carson K; Quintero A; Lafrence M; Malik H; Santana MX; Wolfram J
    Theranostics; 2019; 9(26):8001-8017. PubMed ID: 31754377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles as drug delivery systems: Why and how?
    Elsharkasy OM; Nordin JZ; Hagey DW; de Jong OG; Schiffelers RM; Andaloussi SE; Vader P
    Adv Drug Deliv Rev; 2020; 159():332-343. PubMed ID: 32305351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Extracellular vesicles for renal therapeutics: State of the art and future perspective.
    Tang TT; Wang B; Lv LL; Dong Z; Liu BC
    J Control Release; 2022 Sep; 349():32-50. PubMed ID: 35779658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exosomes and Other Extracellular Vesicles with High Therapeutic Potential: Their Applications in Oncology, Neurology, and Dermatology.
    Szwedowicz U; Łapińska Z; Gajewska-Naryniecka A; Choromańska A
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209095
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
    Chong SY; Lee CK; Huang C; Ou YH; Charles CJ; Richards AM; Neupane YR; Pavon MV; Zharkova O; Pastorin G; Wang JW
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer.
    Kugeratski FG; McAndrews KM; Kalluri R
    Endocrinology; 2021 Mar; 162(3):. PubMed ID: 33411885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery.
    Ingato D; Lee JU; Sim SJ; Kwon YJ
    J Control Release; 2016 Nov; 241():174-185. PubMed ID: 27667180
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics.
    Wu Q; Fu S; Xiao H; Du J; Cheng F; Wan S; Zhu H; Li D; Peng F; Ding X; Wang L
    Adv Sci (Weinh); 2023 Jan; 10(3):e2204814. PubMed ID: 36373730
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma.
    Burgio S; Noori L; Marino Gammazza A; Campanella C; Logozzi M; Fais S; Bucchieri F; Cappello F; Caruso Bavisotto C
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Factors Affecting Extracellular Vesicles Based Drug Delivery Systems.
    Gaurav I; Thakur A; Iyaswamy A; Wang X; Chen X; Yang Z
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33799765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance.
    Ming-Kun C; Zi-Xian C; Mao-Ping C; Hong C; Zhuang-Fei C; Shan-Chao Z
    Cancer Commun (Lond); 2024 Feb; 44(2):205-225. PubMed ID: 38155418
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic potential of extracellular vesicles in neurodegenerative disorders.
    Roudi S; Rädler JA; El Andaloussi S
    Handb Clin Neurol; 2023; 193():243-266. PubMed ID: 36803815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extracellular Vesicles as Biological Shuttles for Targeted Therapies.
    Raimondo S; Giavaresi G; Lorico A; Alessandro R
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30991632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Extracellular Vesicles as Novel Delivery Tools for Cancer Treatment.
    Erkan EP; Saydam O
    Curr Cancer Drug Targets; 2016; 16(1):34-42. PubMed ID: 26412464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineered extracellular vesicles as intelligent nanosystems for next-generation nanomedicine.
    Fan Z; Jiang C; Wang Y; Wang K; Marsh J; Zhang D; Chen X; Nie L
    Nanoscale Horiz; 2022 Jun; 7(7):682-714. PubMed ID: 35662310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Research progress of extracellular vesicles in the treatment of renal disease].
    Tang TT; Lyu LL; Liu BC
    Sheng Li Xue Bao; 2022 Feb; 74(1):67-72. PubMed ID: 35199127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.